Kurzyńska, A.;                     Pach, D.;                     Skalniak, A.E.;                     Stefańska, A.;                     Opalińska, M.;                     Przybylik-Mazurek, E.;                     Hubalewska-Dydejczyk, A.    
        Prevalence of Selected Single-Nucleotide Variants in Patients with Neuroendocrine Tumors—Potential Clinical Relevance. J. Clin. Med. 2022, 11, 5536.
    https://doi.org/10.3390/jcm11195536
    AMA Style
    
                                Kurzyńska A,                                 Pach D,                                 Skalniak AE,                                 Stefańska A,                                 Opalińska M,                                 Przybylik-Mazurek E,                                 Hubalewska-Dydejczyk A.        
                Prevalence of Selected Single-Nucleotide Variants in Patients with Neuroendocrine Tumors—Potential Clinical Relevance. Journal of Clinical Medicine. 2022; 11(19):5536.
        https://doi.org/10.3390/jcm11195536
    
    Chicago/Turabian Style
    
                                Kurzyńska, Anna,                                 Dorota Pach,                                 Anna Elżbieta Skalniak,                                 Agnieszka Stefańska,                                 Marta Opalińska,                                 Elwira Przybylik-Mazurek,                                 and Alicja Hubalewska-Dydejczyk.        
                2022. "Prevalence of Selected Single-Nucleotide Variants in Patients with Neuroendocrine Tumors—Potential Clinical Relevance" Journal of Clinical Medicine 11, no. 19: 5536.
        https://doi.org/10.3390/jcm11195536
    
    APA Style
    
                                Kurzyńska, A.,                                 Pach, D.,                                 Skalniak, A. E.,                                 Stefańska, A.,                                 Opalińska, M.,                                 Przybylik-Mazurek, E.,                                 & Hubalewska-Dydejczyk, A.        
        
        (2022). Prevalence of Selected Single-Nucleotide Variants in Patients with Neuroendocrine Tumors—Potential Clinical Relevance. Journal of Clinical Medicine, 11(19), 5536.
        https://doi.org/10.3390/jcm11195536